Establishment Labs Holdings Incis A Global Medical Technology Company Based In Costa Ricafocusing On Women S Healthparticularly In Breast Aesthetics And Reconstructionfounded In 2004 By Juan Josachaca3N Quira3Sthe Company Went Public In 2018 And Reported $174 5 Million In Revenue For 2024Marking A 34Increase From The Previous Year The Company Develops Silicone Gel Breast Implants Known For Their Safety And Biocompatibilityincorporating Proprietary Surface Technologiesestablishment Labs Also Integrates Rfid Technology Into Its Implants For Identification And Tracking Purposesadditionallythe Company Is Expanding Into Broader Women S Health Technologiesits Primary Customers Include Plastic Surgeons And Healthcare Providersas Well As Women Seeking Aesthetic Or Reconstructive Breast Surgeryestablishment Labs Is Committed To Innovative Solutions That Prioritize Safety And Aesthetic Outcomes
